|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
40,250,000 |
Market
Cap: |
39.14(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.8 - $4.74 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Sesen Bio is a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer. Co.'s main product candidate Vicinium (VB4-845), is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive carcinoma in situ of the bladder in patients previously treated with adequate or less than adequate bacillus Calmette-Guerin. Co.'s lead systemically-administered product candidate, VB6-845d, is being developed as a treatment for multiple types of EpCAM-positive solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
1,428,721 |
Total Sell Value |
$0 |
$0 |
$0 |
$838,716 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
10 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mva Investors, Llc |
10% Owner |
|
2016-06-13 |
4 |
S |
$2.74 |
$2,859,352 |
D/D |
(1,042,000) |
297,860 |
|
- |
|
Mva Investors, Llc |
10% Owner |
|
2016-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,730,572 |
|
- |
|
Mccabe John J |
Senior Vice President, Finance |
|
2016-02-16 |
4 |
S |
$0.27 |
$405 |
D/D |
(1,501) |
8,499 |
|
- |
|
Furfine Eric Steven |
Chief Scientific Officer |
|
2015-12-28 |
4 |
S |
$2.85 |
$13,258 |
D/D |
(4,652) |
34,648 |
|
- |
|
Tubridy Karen L |
Chief Development Officer |
|
2015-12-28 |
4 |
S |
$2.85 |
$12,617 |
D/D |
(4,427) |
32,973 |
|
- |
|
Celniker Abbie |
President and CEO |
|
2015-12-28 |
4 |
S |
$2.85 |
$28,942 |
D/D |
(10,155) |
429,975 |
|
- |
|
Mccabe John J |
Senior Vice President, Finance |
|
2015-08-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
Furfine Eric Steven |
Chief Science Officer |
|
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
39,300 |
39,300 |
|
- |
|
Tubridy Karen L |
Chief Development Officer |
|
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
37,400 |
37,400 |
|
- |
|
Celniker Abbie |
President and CEO |
|
2015-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
85,800 |
440,130 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-05-08 |
4 |
S |
$13.23 |
$441,882 |
D/D |
(33,400) |
1,923,226 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-02-02 |
4 |
S |
$11.62 |
$207,998 |
D/D |
(17,900) |
1,958,826 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-30 |
4 |
S |
$11.77 |
$706,200 |
D/D |
(60,000) |
1,976,726 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-29 |
4 |
S |
$11.46 |
$630,300 |
D/D |
(55,000) |
2,036,726 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-28 |
4 |
S |
$11.58 |
$57,900 |
D/D |
(5,000) |
2,091,726 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-27 |
4 |
S |
$11.66 |
$25,652 |
D/D |
(2,200) |
1,956,626 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-26 |
4 |
S |
$11.50 |
$15,260 |
D/D |
(1,300) |
2,096,726 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-23 |
4 |
S |
$11.57 |
$59,408 |
D/D |
(5,000) |
2,098,026 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-22 |
4 |
S |
$11.58 |
$59,450 |
D/D |
(5,000) |
2,103,026 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-21 |
4 |
S |
$11.50 |
$15,041 |
D/D |
(1,300) |
2,108,026 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-16 |
4 |
S |
$12.00 |
$52,806 |
D/D |
(4,400) |
2,109,326 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-15 |
4 |
S |
$12.00 |
$20,849 |
D/D |
(1,700) |
2,113,726 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2015-01-13 |
4 |
S |
$12.26 |
$51,172 |
D/D |
(4,100) |
2,115,426 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2014-08-26 |
4 |
S |
$11.57 |
$11,570 |
D/D |
(1,000) |
2,119,526 |
|
- |
|
Jafco Super V3 Investment Limited Partnership |
10% Owner |
|
2014-08-25 |
4 |
S |
$11.50 |
$11,500 |
D/D |
(1,000) |
2,120,526 |
|
- |
|
81 Records found
|
|
Page 3 of 4 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|